Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-22T16:38:46.077Z Has data issue: false hasContentIssue false
  • English
  • Français

Observations from a 14-week open-label trial with memantine suggest variable response on behavioral symptoms and cognition, depending on former treatment of AD

Published online by Cambridge University Press:  04 April 2006

PAUL L. J. DAUTZENBERG ,
CEES J. WOUTERS  and
JANET E. M. BOOTSMA
PAUL L. J. DAUTZENBERG
Affiliation:
Department of Geriatrics, Jeroen Bosch Hospital, GV's-Hertogenbosch, The Netherlands. E-mail: [email protected]
CEES J. WOUTERS
Affiliation:
Department of Geriatrics, Jeroen Bosch Hospital, GV's-Hertogenbosch, The Netherlands. E-mail: [email protected]
JANET E. M. BOOTSMA
Affiliation:
Department of Geriatrics, Jeroen Bosch Hospital, GV's-Hertogenbosch, The Netherlands. E-mail: [email protected]
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters
Information
International Psychogeriatrics , Volume 18 , Issue 1 , March 2006 , pp. 179 - 181
Copyright
© International Psychogeriatric Association 2006
Supplementary material: PDF

Download undefined(PDF)
PDF 150.9 KB
Supplementary material: PDF

Dautzenberg Supplementary Material

Tables and figs.pdf

Download Dautzenberg Supplementary Material(PDF)
PDF 75.7 KB